Key result
Rituximab-CHOP and radiation linked to ~80% 5-year progression-free survival in primary mediastinal large B-cell lymphoma.
Rituximab combined with CHOP-like regimens and radiation therapy provides high progression-free survival in PMBCL, though intensive regimens without radiation show promise.
Answers are grounded in this paper and cite their sources.
Supports R-CHOP/CHOP-like plus mediastinal RT in PMBCL; leaves open whether intensive regimens can safely omit radiation.
Primary mediastinal large B-cell lymphoma (PMBCL) is a unique B-cell lymphoma variant that arises from a putative thymic medulla B cell. It constitutes 2-4% of non-Hodgkin lymphomas and occurs most frequently in young females. PMBCL is characterized by a diffuse proliferation of medium-to-large B cells associated with sclerosis. Molecular analysis shows that PMBCL is a distinct entity compared to other types of diffuse large B-cell lymphomas. PMBCL is characterized by a locally invasive anterior mediastinal bulky mass. The combination of rituximab with CHOP/CHOP-like regimens followed by mediastinal radiation therapy (RT) is associated with a 5-year progression-free survival of 75-85%. However, the role of consolidation RT still remains uncertain. More intensive regimens, such as DA-EPOCH-R without mediastinal RT, have shown very promising results. The conclusive role of PET-CT scan requires prospective studies and there is hope that this may allow to de-escalate RT and accordingly yield reliable prognostic information.
No takes yet. Share an insight, caveat, or question.
Martelli et al. (2014) conducted a review in Primary mediastinal large B-cell lymphoma (PMBCL). Rituximab with CHOP/CHOP-like regimens and radiation therapy was evaluated on 5-year progression-free survival. Rituximab with CHOP/CHOP-like regimens followed by mediastinal radiation therapy is associated with a 5-year progression-free survival of 75-85% in primary mediastinal large B-cell lymphoma.
Synapse has enriched 10 related papers. Consider them for comparative context: